Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3365 results

Sort By:

Abscopal Effect from Low-dose Radiotherapy in Metastatic Cancer Combined with Stereotactic Body Radiotherapy

Study ID: NCT05578274
Start Date: 2025-06
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

186

Intervention / Treatment

SBRT + LDRT

SBRT alone

Sponsor

Soonchunhyang University Hospital

Source: clinicaltrials.gov

Share:
Add to list

A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

Study ID: NCT06406465
Start Date: 2025-05-07
End Date: 2028-07-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Whiteness

Cisplatin

Etoposide

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

mHealth-supported Skills Training for Alcohol-Related Suicidality Phase 3

Study ID: NCT05847582
Start Date: 2025-07-01
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

35

Intervention / Treatment

Standard inpatient psychiatric care

Inpatient Skills Training

mHealth-supported Skills Training for Alcohol-Related Suicidality (mSTARS)

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Comparing Effectiveness of Steroids and Methotrexate in Treatment of Chronic Inflammatory Breast Disease

Study ID: NCT06943482
Start Date: 2025-07-01
End Date: 2028-02-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

40

Intervention / Treatment

Prednisolone

Methotrexate

Folic Acid 5 MG

Omeprazole 20 mg

Sponsor

National University Hospital, Singapore

Source: clinicaltrials.gov

Share:
Add to list

SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in P53-Mutated Endometrial Cancer: a Non-Inferiority Randomized Trial

Study ID: NCT06900582
Start Date: 2025-10
End Date: 2031-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

374

Intervention / Treatment

Sentinel Lymph Node Mapping

Comprehensive pelvic and para-aortic lymphadenectomy

Sponsor

University Hospital, Strasbourg, France

Source: clinicaltrials.gov

Share:
Add to list

BC179 Against Alcohol-Induced Damage

Study ID: NCT06899620
Start Date: 2025-05-30
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Probiotic group

Placebo group

Sponsor

Wecare Probiotics Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation

Study ID: NCT06886789
Start Date: 2025-08-01
End Date: 2030-03-29
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Text Messaging

Fully Automated Online Program

Low-Intensity Cardiac Rehabilitation Maintenance Program

High Intensity Cardiac Rehabilitation Maintenance Program

Sponsor

The Miriam Hospital

Source: clinicaltrials.gov

Share:
Add to list

Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries

Study ID: NCT06723392
Start Date: 2025-06
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1134

Intervention / Treatment

Oral nitrofurantoin monohydrate/macrocrystals

Placebo

Sponsor

NICHD Global Network for Women's and Children's Health

Source: clinicaltrials.gov

Share:
Add to list

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Study ID: NCT05733689
Start Date: 2025-06
End Date: 2026-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

ctDNA Blood Test

Nice

FOLFOX

FOLFIRI

FOLFIRINOX

PACLITAXEL with or without CARBOPLATIN

DOCETAXEL and IRINOTECAN (alone or combined)

NIVOLUMAB (alone or when added to a regimen above)

PEMBROLIZUMAB (alone or when added to a regimen above)

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients

Study ID: NCT06911489
Start Date: 2025-07
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

116

Intervention / Treatment

68Ga-NRT6020 Injection

177Lu-NRT6020 Injection (stage 2)

177Lu-NRT6020 Injection (stage 3)

Sponsor

Chengdu New Radiomedicine Technology Co. LTD.

Source: clinicaltrials.gov

Share:
Add to list